文献速递神经肿瘤

丹麦、芬兰和瑞典胶质瘤患者生存与手机使用的关系

Survival of glioma patients in relation to mobile phone use in Denmark, Finland and Sweden.
PubMed 文献 · J Neurooncol · 2018-11-12

该分析基于丹麦、芬兰和瑞典一项既往协作性人群病例对照研究纳入的806例胶质瘤病例,随访其生存状态,采用按国家分层的Cox回归计算风险比(HR)及95%置信区间(CI),评估诊断前手机使用与生存的关联。结果显示,胶质母细胞瘤患者中多种手机使用指标均未提示生存降低,所有显著关联均提示手机使用者生存更好,高级别和低级别胶质瘤结果相似。结论为未发现既往手机使用与胶质瘤患者生存降低相关的证据。

要点

  • 基于806例胶质瘤病例的随访分析未发现诊断前手机使用与生存降低相关。
  • 胶质母细胞瘤患者中,曾规律使用、规律使用起始时间、累计通话时间等指标均未提示生存降低。
  • 所有显著关联均提示手机使用者生存更好,高级别和低级别胶质瘤结果相似。

核心结论

  • 未发现既往手机使用与胶质瘤患者生存降低相关的证据。

研究设计与样本

  • 分析基于丹麦、芬兰和瑞典一项既往协作性人群病例对照研究纳入的806例胶质瘤病例,随访其生存。

主要发现

  • 胶质母细胞瘤患者中,曾规律使用、规律使用起始时间、累计通话时间(总体或近12个月)等手机使用指标相对于未使用或非规律使用均未提示生存降低。
  • 所有显著关联均提示手机使用者生存更好。
  • 高级别和低级别胶质瘤结果相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Gliomas are the most common cancer of the brain, with a poor prognosis in particular for glioblastoma. In 2014, a study suggested reduced survival in relation to latency of mobile phone use among glioblastoma patients. A joint epidemiological/experimental project to study effects of RF-EMF on tumor development and progression was established. The current analysis relates to the epidemiological part and addresses whether pre-diagnostic mobile phone use was associated with survival among glioma patients. METHODS: Glioma cases (n = 806) previously enrolled in a collaborative population-based case-control study in Denmark, Finland and Sweden were followed up for survival. Vital status, date of death, date of emigration, or date last known to be alive was obtained based on registry linkages with a unique personal ID in each country. Cox regression models were used to calculate hazard ratios (HR) and 95% confidence intervals (CI) stratified by country. Covariates investigated were sex, age, education, histology, treatment, anatomic location and marital status. RESULTS: No indication of reduced survival among glioblastoma patients was observed for various measures of mobile phone use (ever regular use, time since start of regular use, cumulative call time overall or in the last 12 months) relative to no or non-regular use. All significant associations suggested better survival for mobile phone users. Results were similar for high-grade and low-grade gliomas. CONCLUSIONS: We found no evidence of reduced survival among glioma patients in relation to previous mobile phone use.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Olsson A, Bouaoun L, Auvinen A, et al. Survival of glioma patients in relation to mobile phone use in Denmark, Finland and Sweden. J Neurooncol. 2018. PMID: 30421160. doi:10.1007/s11060-018-03019-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。